Corvus Pharmaceuticals, Inc. — Director's Dealing 2018

Dec 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2018-12-12

Reporting Person: MILLER RICHARD A MD (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-11	Common Stock, $0.0001 par value	G	10000	$0.00	Disposed	1108795	Indirect
2018-12-11	Common Stock, $0.0001 par value	G	10000	$0.00	Disposed	1098795	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-12	Stock Option (Right to Buy)	$5.94	A	250000	Acquired	2028-12-12	Common Stock (250000)	Direct

Footnotes

F1: A portion of these shares is subject to a right of repurchase held by the Issuer.

F2: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.

F3: The underlying shares subject to the option vest as to one-forty eighth (1/48th) of the shares in successive, equal monthly installments measured from December 12, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.